U.S. Machinery Stock News

Curious whether Silicon Motion Technology is still a bargain or if its stellar run is approaching a peak? Let’s break down what’s really behind the stock’s value. While the share price has surged 58.7% year-to-date and delivered an impressive 74.7% over the last year, it has also pulled back 7.4% this past week, reminding investors that momentum can shift quickly. Much of the recent excitement comes after sector-wide optimism for semiconductor stocks and renewed M&A chatter involving major...

Liberty Broadband Corporation reported a net loss of US$154 million for the third quarter of 2025, compared to net income of US$142 million a year earlier, and completed its latest buyback tranche without repurchasing additional shares during the period. This marks a significant turnaround in quarterly financial performance versus the prior year, raising questions about the factors influencing the company's profit trajectory and capital allocation. We'll explore how Liberty Broadband's...

Icahn Enterprises (IEP) shares have seen some movement lately as investors assess recent performance numbers and the company's longer-term track record. The stock is trading around $8.75, prompting fresh looks at its valuation. See our latest analysis for Icahn Enterprises. Icahn Enterprises has had a bumpy ride over the past year, with the stock’s current $8.75 share price marking a modest recovery from recent lows but still reflecting a 1-year total shareholder return of -14% and deeper...

Gambling.com Group recently reported its third-quarter 2025 financial results, with sales of US$38.98 million, marking an increase from a year ago, but also posted a net loss of US$3.86 million and updated its full-year revenue outlook to around US$165 million due to ongoing search marketing challenges. A standout insight from the announcement is that sports data services revenue grew very rapidly, now contributing roughly a quarter of total revenue and forming a central part of the...

In the past week, Fluor Corporation became the subject of a class action lawsuit alleging it misrepresented financial risks and cost overruns tied to its infrastructure projects, with claims that financial guidance for FY 2025 was unreliable and the impact of economic uncertainty understated. This legal challenge arrives as the company reported a net loss of US$697 million for the third quarter of 2025 and announced new contract wins and share repurchases. We’ll look at how the class action...

Champion Homes (NYSE:SKY) delivered higher sales and net income in the second quarter, backed by a steady share repurchase program. These moves say a lot about how management is steering the business this year. See our latest analysis for Champion Homes. Shares of Champion Homes have rebounded strongly in the past month, with a 14.6% gain in the share price, even after a dip earlier this year. While recent board changes and flat revenue guidance signal some transition, momentum appears to be...

Olin Corporation recently announced a quarterly dividend of US$0.20 per share payable on December 12, 2025, with an ex-date and record date of November 28, 2025, and formed a strategic partnership with Braskem to supply ethylene dichloride as Braskem transforms its Brazilian vinyl assets. This agreement enables Olin to reallocate ethylene dichloride supply toward structurally higher-value, growth-oriented partnerships, reinforcing its global vinyls strategy and integrated chlor-alkali and...

Greenbrier Companies (GBX) shares have experienced some movement over the past month. While the broader market has navigated changing sentiment, investors are now watching closely for signals that might suggest a shift in Greenbrier's current valuation. See our latest analysis for Greenbrier Companies. Greenbrier Companies’ share price has taken a hit in 2024, with a year-to-date decline of nearly 30%. While broader concerns have weighed on rail equipment makers, sentiment appears mixed as...

Titan America (TTAM) shares have moved lower recently, with a drop of nearly 2% at the latest close. Investors are watching to see how the company’s fundamentals might influence its valuation in the current environment. See our latest analysis for Titan America. After a mild pullback in the share price this week, Titan America’s short-term momentum has softened, even after a 3.5% climb over the past month. Looking at the bigger picture, however, the stock’s performance remains cautious for...

Rocket Lab delivered record third-quarter results, reporting US$155.08 million in revenue, a 48% increase year over year, with net losses narrowing significantly compared to the same period last year. The company secured 17 new Electron launch contracts, expanded its backlog to 49 launches, and moved forward with its Neutron rocket development and key acquisitions to bolster its space systems capabilities. We'll examine how Rocket Lab's quarterly revenue growth and expanding launch backlog...

Ascendis Pharma reported third-quarter 2025 results showing revenue of €213.63 million and a net loss of €60.99 million, with improved financial performance, global expansion of key products like YORVIPATH and Skytrofa, and ongoing regulatory progress for its pipeline therapy TransCon CNP. A new pooled analysis revealed sustained three-year improvements in renal function and safety for adults with hypoparathyroidism treated with TransCon PTH, emphasizing the clinical value supporting product...

Urban Outfitters recently launched the next phase of its On Rotation experiential retail concept, collaborating with global lifestyle brand UGG® to create immersive installations in select stores across the US, with the initiative beginning on November 4, 2025. This partnership strengthens Urban Outfitters' position as a gifting destination for the holiday season and highlights its ongoing efforts to connect with Gen Z through unique retail experiences and high-profile brand...

Ever wondered if Sarepta Therapeutics might finally be trading at a price that matches its potential? Let’s dig into what the numbers and the story say about its value right now. The stock has seen a 6.7% jump in the last week. However, this comes after steeper declines of 15.3% over the past month and nearly 85% year-to-date. This makes the current price feel especially intriguing or risky, depending on your outlook. Recent headlines have centered on Sarepta’s evolving lineup of gene...

Centessa Pharmaceuticals recently completed a significant follow-on equity offering, raising approximately US$250 million through the sale of more than 11.6 million American Depositary Shares at US$21.50 each, with additional purchase options granted to underwriters. This capital raise follows a period of increased research and development spending, with proceeds aimed at supporting the advancement of Centessa’s diverse pipeline targeting neurological and neuropsychiatric disorders. We'll...

On November 12, 2025, Modine Manufacturing Company delivered a presentation at the Crypto & AI/Energy Infrastructure Conference in Miami, led by CEO Neil D. Brinker. The company's active engagement at a major event connecting AI and energy infrastructure highlights its ambitions to capitalize on key technology-driven growth sectors. We'll explore how Modine’s focus on data center and energy infrastructure solutions at this conference could impact its investment outlook. Find companies with...

Wondering if Globalstar’s rapid rise means the stock is now a hidden gem or if it is already too rich for your portfolio? You are not alone. Many investors are watching its valuation closely. The share price has increased 133.1% over the past year and is up 98.0% year-to-date, with a surge of 41.2% in just the last month. This suggests a significant change in market sentiment. Much of this momentum can be linked to recent headlines about the company’s technology partnerships...

United States Antimony Corporation recently announced its third quarter 2025 results, reporting revenues of US$8.7 million and a net loss of US$4.78 million, while also securing two major five-year supply contracts with the U.S. government and a domestic industrial manufacturer valued at a combined US$352 million. The new US$106.7 million supply agreement with a U.S. industrial fabric manufacturer highlights growing industrial emphasis on reshoring critical mineral supply chains and seeking...

On November 3, 2025, Credo Technology Group Holding announced Weaver, an advanced memory fanout gearbox designed to dramatically increase memory bandwidth and density for AI accelerators and data centers, leveraging advanced 112G VSR SerDes and proprietary design. This launch directly addresses persistent memory bottlenecks limiting AI inference workloads, offering a unique approach that potentially elevates scalability and performance in next-generation data center applications. We'll...

Tenet Healthcare (THC) is taking major steps to strengthen its balance sheet, wrapping up new debt offerings and securing a multi-year revolving credit facility. These latest moves reshape the company’s financing landscape and extend its debt maturities. See our latest analysis for Tenet Healthcare. The buzz around Tenet Healthcare’s new financing moves has added to the stock’s momentum this year, with a share price now at $192.91 after a strong year-to-date gain of 54.1%. While shares...

Leggett & Platt (LEG) shares have been relatively steady lately, attracting attention as investors weigh up the company’s current valuation compared to its performance over the past year. The stock’s moves hint at ongoing market curiosity. See our latest analysis for Leggett & Platt. Leggett & Platt’s share price has picked up slightly in recent weeks, hinting that some investors are warming up to the stock. However, the longer-term picture remains challenging. While the 1-month share price...

Mirum Pharmaceuticals recently reported strong third-quarter financial results, including a swing to profitability and substantial year-over-year revenue growth, alongside raising its full-year 2025 revenue guidance to the upper end of its prior range. The company also announced new and positive clinical data for its key therapies, LIVMARLI and volixibat, to be featured at the American Association for the Study of Liver Diseases’ (AASLD) 2025 Liver Meeting, underscoring advances in...

Wondering if ZIM Integrated Shipping Services is a diamond in the rough or just another shipping stock? You are not alone, especially with value investors always on the hunt for a good deal. The stock has had quite a ride recently. It jumped 18.0% over the last month and 8.8% in the last week, yet remains down 31.3% year-to-date, hinting at shifts in sentiment and opportunities below the surface. Recent news has focused on industry-wide shipping rate volatility, as well...

The New York Times Company recently announced past third-quarter earnings, reporting revenue of US$700.82 million and net income of US$81.65 million, both higher than the same period last year. Alongside these results, the company completed a significant share repurchase under its existing buyback plan, signaling ongoing capital return to shareholders. We'll examine how this combination of strong earnings growth and continued share buybacks could influence New York Times' investment...

Sensata Technologies (ST) has just shared early results from its latest cash tender offers. The company made headlines by removing the $300 million cap on its STBV 2029 Notes purchases. Investor demand was strong, with tenders exceeding the initial limit and prompting changes to the offer terms. See our latest analysis for Sensata Technologies Holding. While Sensata Technologies’ early tender results and removal of the 2029 Notes purchase cap highlighted strong investor engagement, recent...